» Articles » PMID: 28697967

"New" Bronchopulmonary Dysplasia and Chronic Lung Disease

Overview
Date 2017 Jul 13
PMID 28697967
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchopulmonary dysplasia (BPD) is the major cause of chronic lung disease and morbidity in preterm infants. Since it was first described fifty years ago, the epidemiology, pathogenesis, and treatment for BPD has changed dramatically. This review summarizes these changes and the clinical outcomes for infants diagnosed with BPD.

Citing Articles

[Risk factors for bronchopulmonary dysplasia in preterm infants and establishment of a prediction model].

Liu Y, Yan C, Zhang Y, Weng B, Cai C Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(11):1148-1154.

PMID: 39587742 PMC: 11601104. DOI: 10.7499/j.issn.1008-8830.2404065.


Flexible bronchoscopy in preterm infants with bronchopulmonary dysplasia: findings and complications in a matched control study.

Shemesh Gilboa N, Aviram M, Goldbart A, Hazan G, Arwas N, Hazan I Eur J Pediatr. 2024; 183(11):4837-4845.

PMID: 39245659 DOI: 10.1007/s00431-024-05750-w.


Genetic Ablation of Pyruvate Dehydrogenase Kinase Isoform 4 Gene Enhances Recovery from Hyperoxic Lung Injury: Insights into Antioxidant and Inflammatory Mechanisms.

Watanabe K, Kato A, Adachi H, Noguchi A, Arai H, Ito M Biomedicines. 2024; 12(4).

PMID: 38672101 PMC: 11047825. DOI: 10.3390/biomedicines12040746.


Tenascin-C modulates alveolarization in bronchopulmonary dysplasia.

Liu W, Mao Y, Lv Q, Lu K, Yin C, Cheng R Inflamm Regen. 2024; 44(1):16.

PMID: 38539268 PMC: 10976775. DOI: 10.1186/s41232-024-00330-9.


Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit.

Tang M, Ibrahim A, Laughon C, Moore K, Tejada A, Tran D J Perinatol. 2024; 44(7):953-956.

PMID: 38297180 PMC: 11226392. DOI: 10.1038/s41372-024-01891-w.